Physician

Carlos G Cigarroa, MD

According to 2025 Medicare claims, Carlos Cigarroa, MD (NPI: 1891899084) practices cardiology in the Laredo, TX market, with the plurality of this provider's patient population coming from Webb, TX. This provider's primary affiliated billing organization is CARLOS G CIGARROA, M.D., P.A. (NPI: 1215192364; TIN: 371428064) and primary practice location at 78041-3988.

Cigarroa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,449 traditional Medicare patients, billed 7,395 HCPCS/CPT codes, and received $334,940 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 6,417 prescription claims across 1,001 beneficiaries totaling $658,072 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 38 claims. Open Payments data shows 29 records totaling $795. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $766,107 to $334,940. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $350,792 to $658,072. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $14,377 and ending at $24,114.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,727	16,438	$766,107
2016	2,584	15,221	$750,009
2017	2,459	12,333	$587,116
2018	2,299	12,313	$601,094
2019	2,307	13,369	$662,561
2020	1,884	9,162	$425,585
2021	1,626	9,377	$488,684
2022	1,660	9,018	$456,879
2023	1,479	8,247	$372,686
2024	1,449	7,395	$334,940

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,076	11,564	$350,792
2016	1,044	10,549	$341,502
2017	1,001	9,761	$332,590
2018	1,032	8,893	$404,426
2019	1,141	9,191	$474,145
2020	1,041	8,358	$521,922
2021	961	7,220	$552,184
2022	1,031	7,463	$678,425
2023	995	7,225	$752,831
2024	1,001	6,417	$658,072

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	24	160	$6,493
2016	N/R	171	$5,081
2017	N/R	103	$33,358
2018	N/R	75	$1,351
2019	N/R	73	$3,965
2020	N/R	44	$32,088
2021	N/R	56	$2,067
2022	N/R	24	$1,111
2023	N/R	38	$3,742
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	260	298	$86
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	840	1,961	$80
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	725	934	$52
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	806	1,295	$5
93005	Routine electrocardiogram (ecg) using at least 12 leads with tracing	788	1,248	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	251	12,735	$247,311
Entresto	Sacubitril/Valsartan	155	7,410	$161,838
Xarelto	Rivaroxaban	76	3,284	$54,812
Farxiga	Dapagliflozin Propanediol	44	2,340	$41,327
Januvia	Sitagliptin Phosphate	21	1,170	$20,945

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$795	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carlos G. Cigarroa, MD?

Tedicare shows public-source Medicare data for Carlos G. Cigarroa, MD (NPI 1891899084), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carlos G. Cigarroa, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carlos G. Cigarroa, MD?

Carlos G. Cigarroa, MD is linked to CARLOS G CIGARROA, M.D., P.A. (billing NPI 1215192364) in the available physician profile data.

Does Carlos G. Cigarroa, MD have Open Payments data?

Carlos G. Cigarroa, MD has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.